Pure Global
NCT05823558

Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients

Sisli Hamidiye Etfal Training and Research Hospital·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Osteoporosis
Drug/Device/Intervention
Lomber Muscle Thickness Measurement
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Timeline & enrollment
Phase
N/A
Start date
May 01, 2023
End date
Aug 01, 2023
Enrollment
300 participants
Primary outcome

Lomber Muscle Measurement

Summary

In osteoporosis, sarcopenia is a common condition. Sarcopenic measurements can be made by
 evaluating muscle thickness in different regions. We aim to evaluate lumbar muscle losses in
 patients with osteoporosis in the lumbar region and to examine whether these muscle losses
 are correlated with the level of osteoporosis. The patients will be divided into 3 groups as
 healthy, osteopenic and osteoporotic according to DEXA measurements. Demographic values,
 comorbidities, osteoporosis drugs used, fracture histories, L1-4, L2-4, femoral neck and
 total BMD and t values of the patients, psoas and multifidus muscle measurements will be made
 at L2-L3 level in Lumbar MR imaging. Lumbar MR muscle measurements will be made by 1
 physician blind to the DEXA values of the patients.

ICD-10 classifications
Osteoporosis, unspecifiedOther osteoporosisIdiopathic osteoporosisOsteoporosis in diseases classified elsewherePostmenopausal osteoporosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05823558
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05823558 through Pure Global AI's free database. This phase not specified trial is sponsored by Sisli Hamidiye Etfal Training and Research Hospital and is currently Not yet recruiting. The study focuses on Osteoporosis. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.